Streetbeat News

Stock Prices

AMBI

GRFX

IPW

KSCP

LSH

MNTS

MWG

NVVE

PIXY

SOAR

TAYD

XPON

The article reports on the intraday movements of various industrial stocks. Expion360, iPower, ShiftPixy, Knightscope, Ambipar Emergency, and Lakeside Holding saw significant gains, while Volato Group, Momentus, Taylor Devices, Graphex Gr, Multi Ways Holdings, and Nuvve Holding experienced notable declines.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 4:31 pm

ICG

IONQ

MLNK

OCFT

The article highlights the intraday movements of several information technology stocks on Friday. Notable gainers include OneConnect Financial Tech, Aurora Mobile, and IonQ, while significant losers include Intchains Gr and MeridianLink.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 4:31 pm

DHR

Danaher (NYSE:DHR) has significantly outperformed the market over the past decade, with an annualized return of 18.66%. A $1000 investment in DHR 10 years ago would now be worth $5,524.26, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 4:30 pm

VKTX

Viking Therapeutics (NASDAQ:VKTX) has significantly outperformed the market over the past 5 years, with an annualized return of 55.96%. A $100 investment in VKTX 5 years ago would now be worth $906.54, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 4:30 pm

SSP

Scripps shares rose following the announcement of over 200 job cuts and a reduction in national news programming.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 4:30 pm

IONQ

TMAT

IonQ, Inc. (NYSE:IONQ) shares surged after securing a $54.5 million contract with the US Air Force Research Lab. The company has shown significant growth in sales and revenue, with $72.8 million in bookings year-to-date. IonQ is confident in meeting its annual guidance and has also announced a $9 million agreement with the University of Maryland. Despite a 43% stock decline over the past year, IonQ's recent developments have positively impacted its stock price.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 4:25 pm

BMEA

The FDA has lifted the clinical hold on Biomea Fusion's Phase 1/2 trials for their diabetes treatment candidate BMF-219, following a safety review. The trials had been paused due to concerns over potential liver toxicity. Biomea Fusion's stock saw a slight increase following the news.

Portfolio Pulse from Vandana Singh

September 27, 2024 | 4:20 pm

SLB

XOM

Energy stocks are rising as oil prices increase following an Israeli airstrike on Hezbollah in Beirut. Israeli PM Netanyahu emphasized the right to address threats, impacting the energy sector.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 4:20 pm

ACHC

BMEA

IONQ

NVNO

ONCO

SEEL

U.S. stocks showed mixed performance with the Dow Jones rising, while the NASDAQ and S&P 500 fell. The PCE Price Index increased less than expected, impacting inflation expectations. IonQ, Onconetix, and Biomea Fusion saw significant stock gains due to positive company news, while Seelos Therapeutics, enVVeno Medical, and Acadia Healthcare experienced declines due to various challenges.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 4:15 pm

JNJ

Johnson & Johnson released updated data from two early-stage studies on Talvey combo treatments for multiple myeloma, showing promising response rates and progression-free survival. The studies, RedirecTT-1 and TRIMM-2, demonstrated high overall response rates and complete response rates in patients with relapsed or refractory multiple myeloma.

Portfolio Pulse from Vandana Singh

September 27, 2024 | 4:14 pm